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http:WHAT THIS PAPER ADDS
The routine use of the Walking Impairment Questionnaire is limited by the number of errors when self-
completed and by its scoring complexity. We recently proposed a new simple and easily scored four-item
questionnaire to standardise patient reporting of walking capacity: the “Walking Estimated Limitation Calcu-
lated by History” (WELCH) questionnaire. This study conﬁrms that the accuracy of the WELCH in predicting the
inability to walk for 5 minutes on the treadmill is satisfactory in patients reporting claudication. The WELCH
seems an attractive tool for routine clinical use.Objective: To externally validate the recently proposed “Walking Estimated Limitation Calculated by History”
(WELCH) questionnaire.
Methods: A prospective study was performed on 450 new patients referred to our laboratory for treadmill
testing (constant load 3.2 km/h and 10% slope for 15 minutes and then incremental increases). Results are
presented as mean  SD or median [25the75th percentiles] or number (percentage). An ankle brachial index
<0.90 deﬁned the presence of peripheral artery disease (PAD). Typical “vascular-type claudication” is a lower-
limb pain or discomfort that is absent at rest, appears at exercise, forces stopping, and disappears within 10
minutes of exercise stopping. The Spearman r coefﬁcient of correlation between maximal walking time (MWT) on
treadmill and WELCH scores was calculated for patients with (PADþ) or without (PAD) PAD, and reporting
typical vascular-type claudication (VTCþ) or not (VTC).
Results: The WELCH score was obtained in all included patients. The number (%) of patients with a WELCH score
<25 was 37 (54%), 198 (65%), 14 (44%), and 18 (38%), and the Spearman correlation coefﬁcient between WELCH
score and treadmill MWT was 0.588, 0.609, 0.581, and 0.591 in the VTC/PADþ, VTCþ/PADþ, VTC/PAD, and
VTCþ/PAD groups respectively (all p < .001). In PADþ/VTCþ patients, the WELCH positive predictive value for
the inability to walk for 5 minutes on the treadmill was 79%.
Conclusion: The WELCH score correlates moderately with treadmill-walking capacity in patients with or without
PAD, and with or without typical VTC. It appears to be a simple to complete and easily scored instrument to help
clinicians standardise the subjective estimation of walking capacity in their patients.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Walking limitation is a frequent symptom in elderly pa-
tients. Lower-limb pain or fatigue on exertion may result
from peripheral artery disease (PAD) or various non-
vascular diseases (e.g., lumbar spine, cardio-pulmonary,rresponding author. P. Abraham, Laboratory for Vascular In-
tions, University Hospital, 4 rue Larrey, Angers Cedex 09 F-49933,
.
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-5884/$ e see front matter  2013 European Society for Vascular
. Published by Elsevier Ltd. All rights reserved.
//dx.doi.org/10.1016/j.ejvs.2013.11.010or osteo-articular diseases). The use of standard ques-
tionnaires facilitates and standardises the quantiﬁcation of
walking impairment and provides information additional
to exercise testing.1,2 Among the available tools to esti-
mate walking capacity, the recently proposed “Walking
Estimated Limitation Calculated by History” (WELCH)
questionnaire is of interest because it is simple for pa-
tients to complete and is easily scored.3 Previous publi-
cations have shown that its correlation with the maximal
walking time (MWT) observed during a standard treadmill
test is comparable with the one observed with the more
complex Walking Impairment Questionnaire.3 Further, the
initial validation of the WELCH suggested that a score <25
Figure 1. Example of the scoring of a “Walking Estimated Limitation Calculated by History” (WELCH) questionnaire. Note that item values
and coefﬁcients are presented to facilitate the reading of the ﬁgure, but are not available to the patient.
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with 75% sensitivity and 80% speciﬁcity in PAD patients. In
PAD patients, a walking time of <5 minutes on a treadmill
characterises severe claudication according to the Ruth-
erford classiﬁcation.1,2 As the performance of predictive
models is generally higher with data on which they are
constructed compared with new data,4 so-called “external
validation” was required to conﬁrm our initial ﬁndings
with a new group of patients. Whether the previous cut-
off point (WELCH score <25) proposed to detect pa-
tients with severe claudication (i.e., MWT <5 minutes) is
valid in a prospective study of a new population with PAD
has not been reported.METHODS
Study population
A prospective study was performed from January 2012 on
all new patients referred to our laboratory for treadmill
testing for the diagnosis or follow-up of claudication.5
Eligibility criteria included ability to walk on a treadmill,
native French speakers, age >18 years, stable symptoms for
>3 months, absence of known or apparent cognitive or
psychiatric disorders, and ability to read alone. Written
informed consent was obtained from all patients. Patients
who were referred more than once during the study period
were only included once. Patient characteristics, medical
Figure 2. Flowchart of the study. Note. ABI ¼ ankle brachial index.
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and by patient interview. The study was approved by the
local ethics committee, conforms to the Declaration of
Helsinki, and is an ancillary study of that referenced on the
clinicaltrial.gov website (NCT01114178).
Completion and correction of questionnaires
On arrival, patients were asked to complete the Edinburgh
Claudication Questionnaire (ECQ) and the WELCH ques-
tionnaire. Reading glasses were provided to each patient if
required. The ECQ is used to describe symptoms and does
not evaluate walking capacity. When resulting from PAD,
claudication is expected to fulﬁl vascular-type criteria (VTC)
on the ECQ, including lower-limb pain or discomfort that is
absent at rest, occurs while walking, and that forces the
patient to slow down or stop walking, with pain dis-
appearing within 10 minutes of stopping exercise. Patientswere asked to self-complete the questionnaires while in the
waiting room and were given sufﬁcient time (w15 min) to
complete it, read the information letter, and consent to
their answers being used for research purposes. For those
patients who consented to the study, a trained technician or
nurse screened the questionnaires for errors before the
patient was admitted to the treadmill test room. This
screening searched for missing (no answer to an item),
duplicate (two or more answers to the same item), or
paradoxical (e.g., lower duration for an easier task) answers.
Each detected error was discussed with the patient and
corrected as appropriate.
Walking capacity on treadmill
Thereafter, patients were admitted to the treadmill room.
Characteristics (age, body mass, stature, ankle brachial in-
dex [ABI], current medications) were retrieved from
Table 1. Characteristics of the population.
VTC/PADþ VTCþ/PADþ VTC/PAD VTCþ/PAD
Number of patients 68 303 32 47
Age, years 65  11 65  11 59  15 63  12
Stature, cm 169  10 169  7 170  9 170  7
Body mass, kg 79  17 76  15 81  20 79  15
Bronchitis, n (%) 17 (25) 64 (21) 5 (14) 9 (18)
Hypertension, n (%) 47 (70) 183 (61) 22 (69) 24 (51)
Dyslipidaemia, n (%) 47 (70) 228 (75) 29 (91) 29 (62)
Blood glucose, mg/l 108  28 120  67 100  19 118  54
Haemoglobin, g/l 14.1  1.7 14.1  1.6 14.1  1.7 14.2  1.6
Systolic blood pressure, mmHg 137  13 137  15 137  12 135  13
Diastolic blood pressure, mmHg 82  17 77  9 78  9 74  8
Ankle brachial index 0.69  0.18 0.64  0.18 1.02  0.11 1.00  0.09
Note. VTC ¼ vascular-type claudication; PAD ¼ peripheral artery disease.
322 P. Abraham et al.patient’s ﬁles and completed with the patient if necessary.
The treadmill test was continued to maximum claudication
pain and/or exhaustion. The ﬁrst 15 minutes of treadmill-
walking were performed at 3.2 km/h with a 10% slope
(transition phase from 0 to 3.2 km/h within 1 minute). After
minute 15, the slope and speed were progressively
increased in 1-minute steps, as previously reported.6 With
this procedure (combined constant load and incremental
test) most patients with claudication stop during the con-
stant load phase, but all patients reach their limit on
treadmill. For all tests we recorded MWT in seconds. Phy-
sicians doing the treadmill test were blinded to the result of
the questionnaires.
Classiﬁcation of patients
Patients were classiﬁed based on the presence (PADþ) or
absence (PAD) of PAD. The presence of PAD was deﬁned
as either an ABI at rest <0.90 or a history of lower-limb
arterial revascularisation. Patients with an ABI >1.30 and/
or non-compressible arteries on both sides were excluded
from the study. Further subgroups were deﬁned from the
presence or absence of typical vascular-type claudication in
their answers to the ECQ. Exercise-related typical vascular-
type claudication (VTCþ) was deﬁned from the ECQ as
symptoms fulﬁlling all vascular type criteria. All patients
who were asymptomatic or who reported symptoms not
fulﬁlling these criteria were categorized VTC.
Scoring of the WELCH
An example of the scoring of a WELCH questionnaire is
provided in Fig. 1. The WELCH questionnaire was scored as
previously reported.3 In brief, the completely empirically-
deﬁned scoring is as follows. Each of the eight answers
within the ﬁrst three questionnaire items has a value
ranging from 0 to 7, and each of the ﬁve answers proposed
for the last item dealing with usual walking speed has a
coefﬁcient ranging from 1 to 5. The score is calculated as
the sum of the values found for items 1e3, minus one
(thus, a result ranging from 0 to 20 considering that all
patients are at least able to walk for 30 seconds at the
lowest speed), multiplied by the coefﬁcient found for the
last questionnaire item. As a result, the WELCH score rangesfrom 0 to 100, with 0 indicating a patient that can only walk
for 30 seconds when walking slowly and who usually walks
much slower than relatives, friends, or other people of the
same age. A score of 100 would indicate that the patient
that can walk for 3 hours or more, even when walking fast,
and who usually walks faster than relatives, friends, or
other people of the same age.Sample size calculation and statistical analysis
Results are presented as mean  SD or median [25the75th
percentiles] when appropriate, or number (percentage).
The Spearman coefﬁcient of correlation (r) between MWT
and WELCH scores was calculated. A minimum of 32 pa-
tients was required in each group to estimate the coefﬁ-
cient of correlation with treadmill results with a two-sided
hypothesis, an alpha of 0.05, and a power of 90% with an
anticipated effect size of 0.35. The study was performed
until a sufﬁcient number of patients was included in each
group.
Sensitivity, speciﬁcity, positive and negative predictive
values, and accuracy of a WELCH score <25 in VTCþ or
VTC and PADþ or PAD patients was studied and re-
ported with 95% conﬁdence intervals (CI). Unpaired t tests
were used to compare the results in PADþ versus PAD
patients. Analyses were performed using SPSS V15.0, with
bilateral statistical signiﬁcance set at p < .05.
RESULTS
Inclusion and exclusion processes are presented in Fig. 2.
Note that the rejection rate was 35% during the ﬁrst 6
months of the study and only 10% during the subsequent
12 months. This was probably due to a simpliﬁcation of the
initial administrative procedure where a three-page study
information document and consent form changed to a
simple half-page.Population studied
The characteristics of the 450 included patients are pre-
sented in Table 1. Among these patients, 371 had PAD and
79 did not based on ABI and history. As shown, limitation
was more severe the PADþ patients than PAD patients for
Figure 3. Distribution of the “Walking Estimated Limitation
Calculated by History” (WELCH) scores (upper panel) and maximal
walking time (MWT) on treadmill (lower panel) among the popu-
lation. For the WELCH score, “*” indicates impossible scores.
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(p < .001).Answers to questionnaires
Although all patients were referred to the laboratory for
typical vascular-type claudication, according to the ECQ
data, 14 PADþ patients and 3 PAD patients reported no
claudication. Another 38 PADþ patients and 22 PAD pa-
tients reported pain at rest and exercise, while 16 PADþ
patients and seven PAD patients reported various other
symptoms. Thereby, typical VTC was found in 82% of the
371 PADþ patients and in 59% of the 79 PAD patients.
The WELCH scores were calculated for all patients. The
scores observed in the population are reported in Fig. 3
(upper panel). As shown, the scores do not follow aTable 2. Median [25the75th percentiles] maximal walking time (MW
different groups. Diagnostic performance with percentages (95% con
by History” against the inability to walk for 5 minutes on a treadmill
description of the groups.
VTC/PADþ VTCþ/PA
Number of patients 68 303
MWT, s 254 [123e654] 213 [136
MWT <5 mins 37 (54) 199 (66)
Sensitivity, % 75.7 (59.7e86.8) 79.4 (73.
Speciﬁcity, % 71.0 (53.3e84.1) 61.5 (51.
PPV, % 75.7 (59.7e86.8) 79.8 (73.
NPV, % 71.0 (53.2e84.1) 61.0 (51.
Accuracy, % 73.5 (61.9e82.6) 73.3 (68.
Note. VTC ¼ vascular-type claudication; PAD ¼ peripheral artery dise
values.Gaussian distribution, but rather follow a log-normal type. It
can also be noted from Fig. 3 that, as a result of the scoring
method, some scores are impossible (e.g., no score of 23,
55, or 97 can be found from the calculation
[a þ b þ c  1]$d when “a”, “b”, and “c” range from 0 to 7,
and “d” ranges from 1 to 5). The median WELCH score
observed in PADþ patients was 18 [9e33]. It was signiﬁ-
cantly lower than the WELCH score found in the PAD
group: 30 [16e54] (p < .001). The percentage of patients
with a WELCH score <25 was 54%, 65%, 44%, and 38% in
the VTC/PADþ, VTCþ/PADþ, VTC/PAD, and VTCþ/
PAD groups respectively.MWT on treadmill
As for the WELCH score, the treadmill-measured MWT was
higher, and the proportion of patients with a MWT <5
minutes was lower in PAD than PADþ patients (Table 2).
The distribution of times was not Gaussian, but rather log-
normal (Fig. 3, lower panel).Relationships between MWT and WELCH scores
Despite the fact that both the self-reported and treadmill-
measured walking capacity were different in PADþ and
PAD patients, the different slopes (SE of estimation) of
the relationship (10.3  1.7, 11.0  0.9, 10.5  2.7, and
10.3  2.0), and the Spearman correlation coefﬁcient
(0.588, 0.591, 0.581, and 0.609) of MWT to WELCH score in
the VTC/PADþ, VTCþ/PADþ, VTC/PAD, and VTCþ/
PADþ groups, respectively, were in the same range in all
four groups.
In the 371 PADþ patients, the sensitivity, speciﬁcity,
positive and negative predictive values, and accuracy [95%
CI] of a WELCH score <25 to predict the inability to walk for
5 minutes on treadmill were 78.8% [73.1e83.6], 63.7%
[55.3e71.3], 79.2% [73.5e83.9], 63.2% [54.9e70.9], and
73.3% [68.6e70.8] respectively. Results by groups are pre-
sented in Table 2.
DISCUSSION
The WELCH questionnaire is derived from the Estimated
Ambulatory Capacity by History Questionnaire (EACH-Q).T), and number (%) of patients with a MWT <5 minutes in the
ﬁdence interval) of the “Walking Estimated Limitation Calculated
using a score of 25 as a cut-off value. Please refer to text for the
Dþ VTC/PAD VTCþ/PAD
32 47
e386] 721 [173e1,137] 405 [174e1,071]
9 (28) 19 (40)
2e84.5) 77.8 (44.3e94.7) 63.2 (40.9e81.0)
9e70.3) 69.6 (48.9e84.6) 78.6 (60.1e90.1)
6e84.8) 50.0 (26.8e73.2) 66.7 (43.4e83.9)
4e69.8) 88.9 (66.0e98.1) 75.9 (57.6e88.1)
0e77.9) 71.9 (54.5e84.6) 72.3 (58.1e83.2)
ase; PPV ¼ positive predictive value; NPV ¼ negative predictive
324 P. Abraham et al.The EACH-Q, a questionnaire including four items to
deﬁne walking time sustained at deﬁned paces (three
walking paces and one running pace), was proposed in
2011 as an interesting and relatively simple tool,7 and was
validated in English.8 The limit of the EACH-Q was that,
despite a limited number of items, its scoring remained
relatively complex. We showed that the running item of
the initial EACH-Q score could be skipped without
impairing concordance with treadmill results. Thus, the
EACH-Q could be reduced to three items dealing with the
walking time sustained at three different walking paces.9
In parallel, we showed that asking the patient what his/
her usual walking pace was allowed correction through a
division and multiplication of the score obtained with the
EACH-Q (even so, mental calculation of scoring in this
version was difﬁcult).10 Thus, we recently proposed the
WELCH, which is based on the ﬁrst three items of the
EACH-Q and uses the usual walking speed item (with an-
swers slightly changed), and, overall, uses an empirical,
completely new, and very simple scoring method that can
be calculated mentally without need of a computer.3 The
present study is the latest step in this development pro-
cess. The correlations between WELCH score and treadmill
results observed in this study (ranging from 0.58 to 0.60)
in a large group of patients are consistent, but at the high
end of the expected range of results previously reported
with disease-speciﬁc tools.7,11e13 Reported coefﬁcients
ranged from approximately 0.40 to 0.60, and the number
of studied patients ranged from 4214 to 371.9 It is also
consistent with our previous observation in another pop-
ulation where the Pearson r coefﬁcient of correlation of
the WELCH with MWT was 0.65.3
The non-Gaussian-type distributions observed in Fig. 3
are consistent with previously reported results.3 Further-
more, the WELCH score is not a strictly continuous variable.
Indeed, no prime number above 19 or numbers that are
multiple of a prime number above 19 will ever be observed
owing to the scoring method itself.
Does the moderate correlation between the treadmill-
measured and self-reported score mean that the ques-
tionnaire should not be used? First, there is recent evi-
dence that self-reported capacity correlates better with
community-based measurement of walking disability
than with treadmill results.8 Second, questionnaires
remain essential to estimate the feelings of patients, and
are easy tools for epidemiological studies (e.g., telephone
or mail survey). In the latter case, shorter questionnaires
have a lower risk of rebuttal or errors during self-
completion. From this point of view, the WELCH remains
one of the shortest available questionnaires aimed at
estimating walking disability in patients with suspected
claudication. Preliminary results suggests that it may
discriminate revascularised from non-revascularised pa-
tients,3 but this point has still to be conﬁrmed in a larger
series of patients.
There are limitations to the present study. First, the
proportion of patients that refused to participate was
high. This point is of particular interest when one aims tostudy the routine use of a questionnaire, and underlines
the importance of minimising questionnaire length (as
well as administrative ﬁles) to improve patient accept-
ability. We cannot exclude that it may inﬂuence the results
for the correlation of the WELCH to MWT, although we
think that it is unlikely. Second, in our group, 17.6% of the
patients with claudication had a normal resting ABI and no
history of arterial revascularisation. This proportion is in
the range of previous reports.15,16 It is clear that a certain
proportion of patients in the PAD group (ABI 0.90 at
rest) did have lower-limb arterial disease. Unfortunately,
post-exercise ABI was not used systematically in our
population. Third, the treadmill protocol used here is
speciﬁc and does not allow direct comparison with many
previous studies. The protocol that we used is roughly a
constant load protocol (at least during the ﬁrst 15 minutes
of exercise). The issue with constant load testing is the risk
that some patients have no symptoms or non-limiting
symptoms because the exercise load is less than their
usual walking pace. This was the case in 87 (19%) out of
the 450 studied patients. Thereafter, we performed an
incremental load phase once the patient reached minute
15 of the constant load phase. This resulted in all patients
being symptom-limited on the treadmill, which is of
particular interest when dealing with concordance of self-
reported limitation to avoid any ceiling effect of a con-
stant load test over the results.Direction for future developments
Studies in other groups of patients and other types of
objective walking tests (e.g., Gardner protocol, 6-minute
walking test) are required to conﬁrm our results. Similarly,
evaluation and validation of the WELCH by other centres is
required. Speciﬁcally, the protocol was developed in France
and originally translated into English, but it has not been
validated in a native English-speaking population. Finally,
many studies remain to be done before the WELCH can be
proposed as a routine tool, including determination of
whether or not the WELCH questionnaire is sensitive to
changes in the actual walking capacity; determination of the
long-term reliability of the WELCH score; and the cut-off
limit of score-change that is clinically signiﬁcant at the in-
dividual level to determine an improvement or worsening
of walking capacity.CONCLUSION
This study conﬁrms that the WELCH score correlates with
the walking capacity observed on a treadmill. In PADþ
patients (resting ABI <0.90 or with a history of lower-limb
revascularisation), its value in predicting the inability to
walk for 5 minutes on treadmill is 79.1%. The WELCH
questionnaire therefore appears to be a valid and simple
instrument for subjectively assessing walking limitation.CLINICAL TRIAL REGISTRATION
NIH database: NCT01114178.
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